enGene Therapeutics (ENGN) Interest Expenses (2023 - 2026)
enGene Therapeutics (ENGN) reported Interest Expenses of $843,000 for fiscal Q3 2026 (quarter ended Jul 31, 2026), up 11.2% from $758,000 a year earlier and up 13.2% from the prior quarter.
Powered by 
Analysis
enGene Therapeutics (ENGN) Interest Expenses (2023 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, enGene Therapeutics' Interest Expenses came in at $3.07 million, up 2.3% year-over-year; for FY2025 (ended Oct 31, 2025), it was $2.99 million, up 7.0% from FY2024.
- Interest Expenses has a three-year compound annual growth rate of 28.1% (FY2022 to FY2025).
- By fiscal year, Interest Expenses came in at $2.8 million in FY2024 (-43.5%), $4.95 million in FY2023 (+248.1%) and $1.42 million in FY2022.
- The fiscal Q3 2026 figure ranks as the highest quarterly Interest Expenses since fiscal Q4 2023.
- Year over year, Interest Expenses gained in five of the last eight quarters, with growth averaging 1.2%.
- The high point for year-over-year Interest Expenses in five years was fiscal Q1 2025 (growth of 33.6%); the low point was fiscal Q1 2024 (a decline of 52.1%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $745,000 (Q2 2026), $732,000 (Q1 2026) and $750,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | enGene Therapeutics | 134.03 Mn | 134.03 Mn | - | 843,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 843,000.00 |
| Apr 30, 2026 | 745,000.00 |
| Jan 31, 2026 | 732,000.00 |
| Oct 31, 2025 | 750,000.00 |
| Jul 31, 2025 | 758,000.00 |
| Apr 30, 2025 | 734,000.00 |
| Jan 31, 2025 | 752,000.00 |
| Oct 31, 2024 | 756,000.00 |
| Jul 31, 2024 | 751,000.00 |
| Apr 30, 2024 | 728,000.00 |
| Jan 31, 2024 | 563,000.00 |
| Oct 31, 2023 | 1.16 Mn |
| Jul 31, 2023 | 1.44 Mn |
| Apr 30, 2023 | 1.18 Mn |
| Jan 31, 2023 | 1.18 Mn |
API Access
enGene Therapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();